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Abstract
To determine the impact of a multimodal intervention designed to reduce the incidence of catheter-related bloodstream infections
(CRBSIs) outside the ICU, we conducted a prospective, quasi-experimental, before-after intervention study in 11 hospitals participating
in the VINCat programme in Catalonia, Spain. The intervention consists of: (i) an evidence-based bundle of practices relating to catheter
insertion and maintenance; (ii) a training programme for healthcare workers; (iii) four point–prevalence surveys to track the status of
the catheters; and (iv) feedback reports to the staff involved. The study included both central (CVC) and peripheral venous catheters
(PVCs). Rates of CRBSI per 1000 patient-days were prospectively measured in 2009 (pre-intervention period) and 2010 (post-interven-
tion period). The analysis included 1 191 843 patient-days in 2009 and 1 173 672 patient-days in 2010. The overall incidence of CRBSI
decreased from 0.19 to 0.15 (p 0.04) and the incidence of CRBSI associated with a CVC decreased from 0.14 to 0.10 (p 0.004) after
the intervention. The incidence in PVCs remained unchanged. There was a statistically signiﬁcant improvement in the adequate mainte-
nance of both CVCs and PVCs. Among the CRBSIs originating in PVCs, 61.8% appeared more than 72 h insertion. There was a lower
infection rate in the hospitals with a higher adherence to the recommendation to replace PVCs every 72 h. Our ﬁndings suggest that
the implementation of intervention programmes similar to ours could have a major impact on patient safety by reducing the incidence
of CRBSIs, and that routine replacement of PVCs might additionally prevent a signiﬁcant number of bloodstream infections.
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Introduction
Vascular catheter-related bloodstream infection (CRBSI) is
one of the main forms of nosocomial bacteraemia [1,2]. It is
associated with signiﬁcant morbidity and mortality and has a
high economic impact [1–5]. Most CRBSIs in hospitals occur
in conventional wards [6].
Interventions aimed at reducing CRBSI in the ICU have
shown that the application of a bundle of measures can
result in a signiﬁcant reduction in the incidence of CRBSI [7–
9]. Recently, the need for strategies for preventing CRBSI
outside the ICU has been emphasized [6,10,11]. However,
few interventions have focused on conventional hospital
wards. Measures to reduce CRBSI in this setting need to
modify the practices of a large number of professionals
regarding the management of both central venous catheters
(CVCs) and peripheral venous catheters (PVCs).
The aim of this study was to evaluate the effectiveness of
a multimodal intervention programme for preventing CRBSI
in non-ICU wards. The primary endpoint was the reduction
of CRBSI rates related to both CVCs and PVCs; the second-
ary endpoint was the improvement of adherence to preven-
tive measures. The study was designed by the
VINCat programme (http://vincat.gencat.cat), a standardized
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surveillance system providing risk-adjusted, procedure-spe-
ciﬁc rates of nosocomial infections in Catalonia, Spain.
Methods
Study design, study setting and patient population
This multicentre, prospective, quasi-experimental, before-
after intervention study compared the baseline phase (2009
calendar year) and the intervention phase (2010 calendar
year).
Eleven hospitals afﬁliated to VINCat took part in the
study: four university hospitals with over 500 beds, and
seven general hospitals with under 500 beds. All the adult
patients hospitalized in acute care wards outside the ICU
were included.
Intervention
Between January and December 2010 we carried out a mul-
timodal intervention programme designed by a coordinating
team appointed by the VINCat Technical Committee. Partici-
pating hospitals designated at least one physician and one
nurse to take charge of the project at their centre. The
intervention was divided into four sections.
(i) Proposing evidence-based recommendations [12–16]
for the insertion and maintenance of CVCs and PVCs. Rec-
ommendations for CVCs included hand hygiene, preference
for a subclavian or jugular insertion site rather than a femo-
ral site, full barrier precautions (sterile full body drape, ster-
ile gown, sterile gloves, hair cover, and mask with eye
protection) for insertion, use of 2% chlorhexidine alcohol
solution for skin antisepsis, disinfection of the connector
before access, proper maintenance of the dressing and daily
review of the need for catheterization. Antibiotic-coated
catheters were not used in the participating hospitals. Rec-
ommendations for PVCs included hand hygiene, use of 2%
alcoholic chlorhexidine for skin antisepsis, disinfection of the
connector prior to access, proper maintenance of the dress-
ing, daily review of the need for catheterization and replace-
ment of short PVCs within 72 h of insertion (or 48 h for
those inserted in the emergency department) or in the case
of signs of inﬂammation or extravasation. For both types of
catheter, a transparent semipermeable dressing was used to
cover the catheter exit site during the study period. The
programme was publicized through pocket leaﬂets and post-
ers placed visibly in all the hospital wards, and through train-
ing sessions for the staff. In all, 1000 posters were
distributed at the participating centres. (ii) Staff training. Dur-
ing the ﬁrst quarter of 2010 several training sessions were
held at each of the participating hospitals for medical and
nursing staff. The sessions comprised a standard PowerPoint
presentation highlighting the risks associated with CRBSI,
CRBSI rates in Catalonia, the pathogenesis of infection and
recommendations for prevention. Previously, training had
been provided for the trainers via a meeting with the
researchers at the different centres. Training sessions were
backed up with a prior self-assessment questionnaire con-
taining multiple choice questions on the epidemiology and
prevention of CRBSI. Each hospital informed the coordinat-
ing centre of the sessions held, the number of participants,
and the number of self-assessment questionnaires. (iii) Fol-
low-up and evaluation of the process. The level of adherence
to the recommendations was evaluated by the infection con-
trol teams at each centre by means of point-prevalence sur-
veys, which reviewed all venous catheters inserted in non-
ICU patients, using a structured grid for data collection,
including the number of patients with a venous catheter, the
number and type of catheters, and compliance with the rec-
ommended measures. Table 1 shows the items evaluated
and the criteria used. Surveys were conducted at baseline,
before the dissemination of the recommendations, and then
every 2 months during the study. At the end of each of
these controls, feedback was given to healthcare workers on
the ward in the form of a report with the results on the rate
of adherence to the recommendations and the problems
identiﬁed. The results obtained at each hospital were sent to
the coordinating centre for pooled analysis. (iv) Giving infor-
mation to the health staff regarding all cases of CRBSI. The
team responsible for patient care received written informa-
tion about each case, and possible areas for improvement
were discussed.
Detection of cases of CRBSI and deﬁnitions
Surveillance of CRBSI episodes was conducted by a multidis-
ciplinary team at each centre, which performed daily evalua-
tion of hospitalized patients with positive blood cultures.
Table 2 shows the criteria used for the diagnosis of CRBSI.
TABLE 1. Criteria used to evaluate the catheter mainte-
nance status at each point-prevalence study
Items evaluated Criteria
Catheter was needed The catheter had been used in the last 24 h, or
procedures requiring its presence were scheduled.
PVC dwell time
was correct
The catheter was in situ <72 h or <48 h if it was
inserted in the emergency department.
Dressing was intact The dressing was clean and adhering to the skin
The infusion set
was correct
No blood was visible and a protective cap was in
place if the equipment was disconnected.
No phlebitis Absence of induration, pain or signs of inﬂammation
at the insertion point or in the catheter trajectory.
Catheter use was
recorded
Information in the clinical records included the date
of insertion and catheter size.
PVC, peripheral venous catheter.
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All hospital-acquired bloodstream infections related to CVC
(including peripherally inserted central venous catheters) or
PVC (both short-line and mid-line) were included. CRBSI
acquired outside the hospital and those originating in
implantable vascular ports were excluded.
Statistical analysis
Incidence density of CRBSI was calculated as episodes of
bloodstream infection per 1000 patient-days, according to
the VINCat Program criteria [17]. Patient-days were
obtained from administrative data. In addition, an estimation
of CRBSI rate per 1000 catheter-days was carried out, as
reported by Trinh et al. [18]. To estimate catheter-days, we
obtained the total adult patient-days at each centre during
the study period and then multiplied it by the mean preva-
lence rate of catheter use at each centre in the ﬁve point-
prevalence studies conducted during the study.
Descriptive analysis was performed using means and stan-
dard deviation or median and interquartile range for continu-
ous variables and percentages with 95% conﬁdence intervals
for categorical variables. To assess the impact of the interven-
tion, we compared the incidence density of CRBSI obtained
at all participating hospitals during 2010 with that obtained in
2009 using the incidence rates comparison test through the Z
statistic. To assess the impact of the intervention on the
implementation of preventive measures, we compared the
adherence rates observed in the baseline point-prevalence
study with those observed at the four subsequent pooled
time-points using the proportion comparison test for inde-
pendent samples through the Z statistic. In addition, we com-
pared the median duration of catheter insertion time before
bacteraemia for each type of catheter by year (2010 com-
pared with that obtained in 2009) using the Mann–Whitney
U-test. A p value of 0.05 or less was considered statistically
signiﬁcant. Statistical analyses were performed using SPSS
V12.0 (SPSS Inc., Chicago, IL, USA) and EPIDAT V 3.1.
Results
The participating centres included 4304 beds, with a total of
1 191 843 patient-days in 2009 and 1 173 672 patient-days in
2010.
In total, 2176 healthcare workers participated in the train-
ing sessions held at the participating hospitals. In the surveys
conducted before the training sessions, the mean score
obtained was 58 out of a maximum of 100. The mean level
of knowledge was higher for nurses (62 ± 19) than for physi-
cians (57 ± 17) or nursing assistants (50 ± 23).
In the period after the multimodal intervention a statisti-
cally signiﬁcant reduction was recorded in the overall inci-
dence of CRBSI (Table 3). This decrease was due to a
reduction in CRBSI originating in CVCs, particularly in hospi-
tals with over 500 beds (Table S1 in supporting information),
TABLE 2. Deﬁnition of venous catheter-related bloodstream infection
Bacteraemia or fungaemia in a patient with a venous catheter with at least one set of positive blood cultures obtained from a peripheral vein (or two sets in the case of habitual
skin-colonizing microorganisms).
and
Clinical manifestations of infections (i.e. fever, chills, and or hypotension) in the absence of an apparent source of the bloodstream infection other than the catheter.
and one of the following:
Positive semi-quantitative culture (>15 CFU/catheter segment) or quantitative (>103 CFU/catheter segment) with the same microorganism as in the blood cultures
obtained from the peripheral blood.
Simultaneous quantitative blood cultures with a ‡5:1 ratio catheter vs. peripheral.
Difference in time to positivity of the blood cultures of above 2 h between the cultures obtained from a peripheral vein and those obtained from the lumen of a catheter.
A culture of the secretion in the insertion point shows growth of the same microorganism detected in the blood cultures.
Resolution of clinical signs and symptoms after the withdrawal of the catheter with or without appropriate antibiotic treatment (this will be accepted as a condition
if it was not possible to perform the above procedures).
For the clinical diagnosis of peripheral venous catheter-related bloodstream infection, the presence of signs of phlebitis is required.
CFU, colony forming units.
TABLE 3. Catheter-related bloodstream infections in the pre-intervention (2009) and post-intervention (2010) periods
Catheter
type
2009 2010
p
No. of
CRBSI
No. of
patient-days
CRBSI per
1000 patient-days 95% CI
No. of
CRBSI
No. of
patient-days
CRBSI per
1000 patient-days 95% CI
CVC 166 1 191 843 0.14 0.12–0.16 115 1 173 672 0.10 0.08–0.11 0.004
PVC 54 1 191 843 0.05 0.03–0.6 61 1 173 672 0.05 0.04–0.07 0.52
Overall 220 1 191 843 0.19 0.16–0.21 176 1 173 672 0.15 0.13–0.18 0.04
CRBSI, catheter-related bloodstream infections; CVC, central venous catheter (also including peripherally inserted central venous catheters); PVC, peripheral venous
catheter.
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while the incidence of cases due to PVCs remained
unchanged. When the incidence of CRBSI was calculated as
episodes per 1000 estimated catheter-days, a similar signiﬁ-
cant reduction was observed in the overall incidence of
CRBSI and in CRBSI originating in PVCs (results are shown
in Table S2 in supporting information).
The median duration of CVC before bloodstream infec-
tion was 13 days (interquartile range, 8–23 days) in 2009 and
11 days (interquartile range, 6–19 days) in 2010 (p 0.20). In
PVCs, the corresponding ﬁgures were 4 days (interquartile
range, 3–6) for both 2009 and 2010. In the case of short
peripheral venous catheters, in which replacement was rec-
ommended after 72 h of insertion, 35 infections (63.3%)
occurred after the ﬁrst 72 h of insertion in 2009, while 34
infections (61.8%) appeared after this interval in 2010.
Table 4 shows the microorganisms responsible for CRBSI
in the two periods. In the post-intervention period, the inci-
dence of Gram-positive cocci CRBSI decreased signiﬁcantly
from 0.16 to 0.11 episodes per 1000 patient-days (p 0.003),
mainly due to a reduction in CVC-BSI, whereas the incidence
of Gram-negative bacilli CRBSI increased slightly from 0.02
to 0.03 episodes per 1000 patient-days (p 0.44). The inci-
dence of Staphylococcus aureus CRBSI decreased from 0.05 to
0.04 episodes per 1000 patient-days, although the difference
was not statistically signiﬁcant (p 0.18). S. aureus was the
main organism responsible for PVC-BSI, accounting for
68.4% in the pre-intervention period and 52.3% in the post-
intervention period (p 0.07).
Table 5 shows the results regarding adherence to preven-
tive measures observed in the point-prevalence studies.
TABLE 4. CRBSI causative microorganisms in pre-intervention and post-intervention periods
Microorganism
2009 2010
p*Overall N (%) CVC N (%) PVC N (%) Overall N (%) CVC N (%) PVC N (%)
Gram-positive microorganisms 195 (82.6) 145 (81.0) 50 (87.7) 138 (72.6) 88 (69.3) 50 (79.4) 0.01
CoNS 113 (47.9) 103 (57.5) 10 (17.5) 67 (35.3) 55 (43.3) 12 (19.0) 0.01
Staphylococcus aureus 71 (30.0) 32 (17.9) 39 (68.4) 54 (28.4) 21 (16.5) 33 (52.3) 0.78
MSSA 63 (26.7) 29 (16.2) 34 (59.6) 49 (25.8) 21 (16.5) 28 (44.4) 0.92
MRSA 8 (3.4) 3 (1.7) 5 (8.8) 5 (2.6) – 5 (7.9) 0.86
Enterococcus spp. 9 (3.8) 8 (4.5) 1 (1.8) 13 (6.8) 10 (7.9) 3 (4.8) 0.23
Miscellaneous 2 (0.8) 2 (1.1) – 4 (2.1) 2 (1.6) 2 (3.2) 0.49
Gram-negative microorganisms 33 (14.0) 26 (14.5) 7 (12.3) 40 (21.1) 28 (22.0) 12 (19.0) 0.07
Escherichia coli 3 (1.3) 3 (1.7) – 4 (2.1) 4 (3.1) – 0.77
Klebsiella spp. 12 (5.1) 11 (6.1) 1 (1.8) 12 (6.3) 6 (4.7) 6 (9.5) 0.73
Proteus spp. 2 (0.8) 2 (1.1) – 1 (0.5) 1 (0.8) – 0.85
Pseudomonas aeruginosa 6 (2.5) 6 (3.4) – 3 (1.6) 3 (2.4) – 0.72
Enterobacter species 7 (3.0) 3 (1.7) 4 (7.0) 13 (6.8) 10 (7.9) 3 (4.8) 0.09
Miscellaneous 3 (1.3) 1 (0.6) 2 (3.5) 7 (3.7) 4 (3.1) 3 (4.8) 0.18
Candida spp. 8 (3.4) 8 (4.5) – 12 (6.3) 11 (8.7) 1 (1.6) 0.23
All microorganisms 236 (100) 179 (100) 57 (100) 190 (100) 127 (100) 63 (100)
Polymicrobial bloodstream infection 16 13 3 14 12 2
*Overall BSI-CV 2009 vs. overall BSI-CV 2010.
CVC, central venous catheter (also including peripherally inserted central venous catheters); PVC, peripheral venous catheter; CoNS, coagulase-negative staphylococci; MSSA,
methicillin-sensitive Staphylococcus aureus; MRSA, methicillin-resistant Staphylococcus aureus.
TABLE 5. Adherence to the recommended precautionary measures evaluated in the point-prevalence studies*
Item evaluated
Central venous cathetersa Peripheral venous catheters
p
Baseline
observation (266
catheters)
Follow-up
observationsb (877
catheters)
Baseline observation
(1809 catheters)
Follow-up
observationsb (5654
catheters)
No. % (95% CI) No. % (95% CI) p No. % (95% CI) No. % (95% CI)
Catheter was needed 254 95.5 (92.3–97.7) 831 94.8 (93.1–96.1) 0.75 1512 83.6 (81.9–85.3) 4832 85.5 (84.5–86.4) 0.05
PVC dwell time was correct NA NA NA NA – 1156 63.9 (61.7–66.1) 4193 74.2 (73.0–75.3) <0.001
Dressing was intact 212 79.7 (74.9–84.5) 791 90.2 (88.0–92.1) <0.0001 1406 78.7 (75.8–79.6) 4904 86.7 85.9–87.6) <0.001
The infusion set was correct 231 86.8 (82.8–90.9) 772 88.0 (85.9–90.2) 0.68 1491 82.4 (80.7–84.2) 4514 79.8 (78.8–80.9) 0.02
No phlebitis 266 100 (98.6–100) 867 98.9 (97.9–99.5) 0.16 1764 97.5 (96.7–98.2) 5487 97.0 (96.6–97.5) 0.33
Catheter use was recorded 231 86.8 (82.8–90.9) 782 89.2 (87.1–91.2) 0.34 1446 79.9 (78.1–81.8) 4849 85.8 (84.9–86.7) <0.001
All the items evaluated
were correct
159 59.8 (53.9–65.7) 631 72.0 (69.0–74.9) <0.001 785 43.4 (41.1–45.7) 3080 54.5 (53.2–55.8) <0.001
*Results are expressed as percentage of catheters fulﬁlling the recommendation.
aAlso including peripherally inserted central venous catheters.
bThe four point-prevalence studies performed after the dissemination of the recommendations are pooled together.
NA, not applicable.
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There was a statistically signiﬁcant improvement in the
implementation of the measures in the post-intervention per-
iod for both central and peripheral catheters. The measure
with the lowest level of adherence was the recommendation
to replace short PVCs at 72 h after insertion: in spite of this
speciﬁc recommendation, 25.8% of PVCs remained in place
beyond this time-point. The three participating hospitals with
a lower proportion (<15%) of PVCs in place for more than
72 h, according to the follow-up point-prevalence studies,
obtained a lower rate of CRBSI originating in PVCs, as com-
pared with the eight hospitals with a higher proportion of
PVCs in place for more than 72 h (0.02 vs 0.06 per 1000
patient-days; p 0.05).
Discussion
The implementation of a programme designed to decrease
the rate of CRBSI originating in conventional hospital wards
achieved a signiﬁcant reduction over the period of 1 year.
This decrease was due to the 30% fall in infections originat-
ing in central venous catheters, while the incidence of PVC-
BSI did not change signiﬁcantly. The programme also
achieved a signiﬁcant improvement in the adequate mainte-
nance of intravenous catheters, evaluated in four point-prev-
alence studies after the start of the programme, especially
regarding the state of preservation of the dressings and the
replacement of PVCs. Although the improvement was
observed for both central and peripheral catheters, the rate
of catheters fulﬁlling all the items evaluated during the point-
prevalence studies was lower in the PVC group compared
with CVC group (54.5% vs. 72%), probably due to the high
number of healthcare workers involved in the insertion and
maintenance of PVCs and the generally low perception of
the risk of complications associated with their use.
There are few published data on CRBSI rates outside the
ICU. For CVCs, studies from different countries and settings
showed a rate from 1.2 to 7.7 cases per 1000 catheter-days
[19–22]. Few previous studies have shown reductions in the
rate of CRBSI after introducing speciﬁc measures for cathe-
ter insertion and maintenance outside the ICU [23–25].
These studies are based on educational and feedback inter-
ventions. The widespread implementation of intervention
programmes similar to ours could have a major impact on
patient safety, with signiﬁcant reductions in morbidity, mor-
tality and cost. With regard to PVCs, the information is very
limited. A systematic review reported an average incidence
of 0.5 cases per 1000 catheter-days for short plastic cathe-
ters and 8.6 for steel needles [26]. In our study, as in other
previous studies [18,27], a signiﬁcant proportion of cases
were caused by S. aureus, showing a potential for serious
complications and high mortality [28–31]. Signiﬁcantly, over
60% of CRBSI originating in short PVCs appeared more than
72 h after insertion of the catheter. Moreover, participating
hospitals with a higher adherence to removing PVCs when
recommended, obtained a lower rate of CRBSI originating in
PVCs. Both facts suggest that strict adherence to the recom-
mendation of routine catheter replacement could have pre-
vented a signiﬁcant number of cases, but often healthcare
workers appear reluctant to follow this recommendation
[32,33]. Although a recent meta-analysis indicated that rou-
tine replacement of peripheral catheters does not reduce
the risk of infection [34], the study may have been under-
powered to address the issue of CRBSI because the data
analysed included only 8779 catheter-days, a ﬁgure too low
to assess a risk of between 0.1 and 0.5 cases per 1000 days.
Interestingly, the application of a bundle in a Irish hospital
including the replacement of PVC within 72 h reduced cases
of CRBSI due to S. aureus [35]. More recently, a controlled
study of education and feedback in Detroit (USA), incorpo-
rating a recommendation to replace PVCs within 96 h,
obtained a signiﬁcant reduction in PVC-associated blood-
stream infection [36].
Our study has several limitations. First, it is not a random-
ized study, with the resulting risk of bias due to confounding
factors. However, we believe that the prospective multicen-
tre nature of the study and the proximity in time of the
baseline and post-intervention periods reduce this risk. Sec-
ond, the CRBSI incidence is expressed per 1000 patient-days
instead of catheter-days. However, continuous monitoring of
all patients with venous catheters outside the ICU would
have required a great deal of resources and entailed exces-
sive costs to the participating hospitals. This prevents com-
paring our rates with other studies expressing the rates per
catheter-days, and also may prevent identiﬁcation of the
dwell-time of CVC that beneﬁted most from the interven-
tion. Third, the methodology used to study adherence to the
recommendations focused on the state of the catheters
observed through the four prevalence studies, but did not
include observational studies on adherence to the measures
recommended at the time of catheter insertion.
In conclusion, this multimodal intervention signiﬁcantly
reduced the overall rate of CRBSI outside the ICU and the
rate of CRBSI originating in CVCs. However, the interven-
tion was unable to decrease the rate of CRBSI originating in
PVCs. Our ﬁndings suggest that the implementation of inter-
vention programmes similar to ours could have a major
impact on patient safety and that routine replacement of
peripheral catheters may additionally prevent a signiﬁcant
number of bloodstream infections.
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